APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Active and Intelligent Packaging

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Active and Intelligent Packaging Market Outlook and Growth Opportunities 2026

Report ID 173327780410 April 2026Not stated

Choose your research edition.

Industry ResearchPharmaceutical Active and Intelligent Packaging Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Active and Intelligent Packaging Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Active and Intelligent Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Active and Intelligent Packaging Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Active and Intelligent Packaging Market Analysis and Forecast 2026-2032259 pages · $4,950 USD

Market perspective

The global Pharmaceutical Active and Intelligent Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Active and Intelligent Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Active and Intelligent Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Active and Intelligent Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Active and Intelligent Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Active and Intelligent Packaging market include BASF, WestRock Company, Timestrip UK, Sonoco Products, Sealed Air Corporation, Landec, Honeywell International, Graphic Packaging and Dessicare, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Active and Intelligent Packaging market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Active and Intelligent Packaging and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Active and Intelligent Packaging revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Active and Intelligent Packaging market.

Pharmaceutical Active and Intelligent Packaging Segment by Company

BASF

WestRock Company

Timestrip UK

Sonoco Products

Sealed Air Corporation

Landec

Honeywell International

Graphic Packaging

Dessicare

Crown Holdings

Coveris Holdings

CCL Industrie

Bemis Company

Ball Corporation

Amcor

Pharmaceutical Active and Intelligent Packaging Segment by Type

Active Packaging

Intelligent Packaging

Pharmaceutical Active and Intelligent Packaging Segment by Application

Human Medicine

Veterinary Medicine

Pharmaceutical Active and Intelligent Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Active and Intelligent Packaging status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Active and Intelligent Packaging key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Active and Intelligent Packaging breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Active and Intelligent Packaging market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Active and Intelligent Packaging significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Active and Intelligent Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Active and Intelligent Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Active and Intelligent Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Active and Intelligent Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Active and Intelligent Packaging industry.

Chapter 3: Detailed analysis of Pharmaceutical Active and Intelligent Packaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Active and Intelligent Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Active and Intelligent Packaging in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Active and Intelligent Packaging Industry Trends Table 2. Pharmaceutical Active and Intelligent Packaging Industry Drivers Table 3. Pharmaceutical Active and Intelligent Packaging Industry Opportunities and Challenges Table 4. Pharmaceutical Active and Intelligent Packaging Industry Restraints Table 5. Global Pharmaceutical Active and Intelligent Packaging Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Active and Intelligent Packaging Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Active and Intelligent Packaging Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Active and Intelligent Packaging Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Active and Intelligent Packaging Company, Product Type & Application Table 10. Global Pharmaceutical Active and Intelligent Packaging Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Active and Intelligent Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Active Packaging Table 15. Significant Companies of Intelligent Packaging Table 16. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type (2021-2026) Table 20. Global Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Human Medicine Table 22. Significant Companies of Veterinary Medicine Table 23. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application (2021-2026) Table 27. Global Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application (2027-2032) Table 28. Global Pharmaceutical Active and Intelligent Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Pharmaceutical Active and Intelligent Packaging Sales Value Share by Region (2021-2026) Table 31. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Pharmaceutical Active and Intelligent Packaging Sales Value Share by Region (2027-2032) Table 33. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Pharmaceutical Active and Intelligent Packaging Sales Value Market Share by Country (2021-2026) Table 36. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Pharmaceutical Active and Intelligent Packaging Sales Value Market Share by Country (2027-2032) Table 38. BASF Company Information Table 39. BASF Business Overview Table 40. BASF Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. BASF Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 42. BASF Recent Development Table 43. WestRock Company Company Information Table 44. WestRock Company Business Overview Table 45. WestRock Company Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. WestRock Company Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 47. WestRock Company Recent Development Table 48. Timestrip UK Company Information Table 49. Timestrip UK Business Overview Table 50. Timestrip UK Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Timestrip UK Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 52. Timestrip UK Recent Development Table 53. Sonoco Products Company Information Table 54. Sonoco Products Business Overview Table 55. Sonoco Products Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Sonoco Products Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 57. Sonoco Products Recent Development Table 58. Sealed Air Corporation Company Information Table 59. Sealed Air Corporation Business Overview Table 60. Sealed Air Corporation Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Sealed Air Corporation Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 62. Sealed Air Corporation Recent Development Table 63. Landec Company Information Table 64. Landec Business Overview Table 65. Landec Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Landec Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 67. Landec Recent Development Table 68. Honeywell International Company Information Table 69. Honeywell International Business Overview Table 70. Honeywell International Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Honeywell International Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 72. Honeywell International Recent Development Table 73. Graphic Packaging Company Information Table 74. Graphic Packaging Business Overview Table 75. Graphic Packaging Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Graphic Packaging Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 77. Graphic Packaging Recent Development Table 78. Dessicare Company Information Table 79. Dessicare Business Overview Table 80. Dessicare Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Dessicare Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 82. Dessicare Recent Development Table 83. Crown Holdings Company Information Table 84. Crown Holdings Business Overview Table 85. Crown Holdings Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Crown Holdings Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 87. Crown Holdings Recent Development Table 88. Coveris Holdings Company Information Table 89. Coveris Holdings Business Overview Table 90. Coveris Holdings Pharmaceutical Active and Intelligent Packaging Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. Coveris Holdings Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 92. Coveris Holdings Recent Development Table 93. CCL Industrie Company Information Table 94. CCL Industrie Business Overview Table 95. CCL Industrie Pharmaceutical Active and Intelligent Packaging Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 96. CCL Industrie Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 97. CCL Industrie Recent Development Table 98. Bemis Company Company Information Table 99. Bemis Company Business Overview Table 100. Bemis Company Pharmaceutical Active and Intelligent Packaging Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 101. Bemis Company Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 102. Bemis Company Recent Development Table 103. Ball Corporation Company Information Table 104. Ball Corporation Business Overview Table 105. Ball Corporation Pharmaceutical Active and Intelligent Packaging Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 106. Ball Corporation Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 107. Ball Corporation Recent Development Table 108. Amcor Company Information Table 109. Amcor Business Overview Table 110. Amcor Pharmaceutical Active and Intelligent Packaging Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 111. Amcor Pharmaceutical Active and Intelligent Packaging Product Portfolio Table 112. Amcor Recent Development Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Pharmaceutical Active and Intelligent Packaging Product Image Figure 2. Global Pharmaceutical Active and Intelligent Packaging Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Active and Intelligent Packaging Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Active and Intelligent Packaging Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Active Packaging Image Figure 8. Intelligent Packaging Image Figure 9. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pharmaceutical Active and Intelligent Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type (2021-2032) Figure 12. Human Medicine Image Figure 13. Veterinary Medicine Image Figure 14. Global Pharmaceutical Active and Intelligent Packaging Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pharmaceutical Active and Intelligent Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application (2021-2032) Figure 17. Global Pharmaceutical Active and Intelligent Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Pharmaceutical Active and Intelligent Packaging Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Pharmaceutical Active and Intelligent Packaging Sales Value (2021-2032) & (US$ Million) Figure 20. North America Pharmaceutical Active and Intelligent Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Pharmaceutical Active and Intelligent Packaging Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Pharmaceutical Active and Intelligent Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Pharmaceutical Active and Intelligent Packaging Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Pharmaceutical Active and Intelligent Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Pharmaceutical Active and Intelligent Packaging Sales Value (2021-2032) & (US$ Million) Figure 26. South America Pharmaceutical Active and Intelligent Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Pharmaceutical Active and Intelligent Packaging Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Pharmaceutical Active and Intelligent Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Active Packaging
  • Intelligent Packaging
Applications
  • Human Medicine
  • Veterinary Medicine
Companies covered
  • BASF
  • WestRock Company
  • Timestrip UK
  • Sonoco Products
  • Sealed Air Corporation
  • Landec
  • Honeywell International
  • Graphic Packaging
  • Dessicare
  • Crown Holdings
  • Coveris Holdings
  • CCL Industrie
  • Bemis Company
  • Ball Corporation
  • Amcor

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Active and Intelligent Packaging Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Active and Intelligent Packaging Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Active and Intelligent Packaging Market Dynamics
  1. 2.1 Pharmaceutical Active and Intelligent Packaging Industry Trends
  2. 2.2 Pharmaceutical Active and Intelligent Packaging Industry Drivers
  3. 2.3 Pharmaceutical Active and Intelligent Packaging Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Active and Intelligent Packaging Industry Restraints
3 Pharmaceutical Active and Intelligent Packaging Market by Company
  1. 3.1 Global Pharmaceutical Active and Intelligent Packaging Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Active and Intelligent Packaging Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Active and Intelligent Packaging Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Active and Intelligent Packaging Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Active and Intelligent Packaging Company Product Type and Application
  6. 3.6 Global Pharmaceutical Active and Intelligent Packaging Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Active and Intelligent Packaging Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Active and Intelligent Packaging Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Active and Intelligent Packaging Market by Type
  1. 4.1 Pharmaceutical Active and Intelligent Packaging Type Introduction
  2. 4.1.1 Active Packaging
  3. 4.1.2 Intelligent Packaging
  4. 4.2 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Type
  5. 4.2.1 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type (2021-2032)
5 Pharmaceutical Active and Intelligent Packaging Market by Application
  1. 5.1 Pharmaceutical Active and Intelligent Packaging Application Introduction
  2. 5.1.1 Human Medicine
  3. 5.1.2 Veterinary Medicine
  4. 5.2 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Application
  5. 5.2.1 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Application (2021-2032)
  7. 5.2.3 Global Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application (2021-2032)
6 Pharmaceutical Active and Intelligent Packaging Regional Value Analysis
  1. 6.1 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Active and Intelligent Packaging Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Active and Intelligent Packaging Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Active and Intelligent Packaging Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Active and Intelligent Packaging Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Active and Intelligent Packaging Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Active and Intelligent Packaging Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Active and Intelligent Packaging Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Active and Intelligent Packaging Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Active and Intelligent Packaging Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Active and Intelligent Packaging Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Active and Intelligent Packaging Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Active and Intelligent Packaging Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Active and Intelligent Packaging Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Active and Intelligent Packaging Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Active and Intelligent Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF
  2. 8.1.1 BASF Company Information
  3. 8.1.2 BASF Business Overview
  4. 8.1.3 BASF Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BASF Pharmaceutical Active and Intelligent Packaging Product Portfolio
  6. 8.1.5 BASF Recent Developments
  7. 8.2 WestRock Company
  8. 8.2.1 WestRock Company Company Information
  9. 8.2.2 WestRock Company Business Overview
  10. 8.2.3 WestRock Company Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  11. 8.2.4 WestRock Company Pharmaceutical Active and Intelligent Packaging Product Portfolio
  12. 8.2.5 WestRock Company Recent Developments
  13. 8.3 Timestrip UK
  14. 8.3.1 Timestrip UK Company Information
  15. 8.3.2 Timestrip UK Business Overview
  16. 8.3.3 Timestrip UK Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Timestrip UK Pharmaceutical Active and Intelligent Packaging Product Portfolio
  18. 8.3.5 Timestrip UK Recent Developments
  19. 8.4 Sonoco Products
  20. 8.4.1 Sonoco Products Company Information
  21. 8.4.2 Sonoco Products Business Overview
  22. 8.4.3 Sonoco Products Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sonoco Products Pharmaceutical Active and Intelligent Packaging Product Portfolio
  24. 8.4.5 Sonoco Products Recent Developments
  25. 8.5 Sealed Air Corporation
  26. 8.5.1 Sealed Air Corporation Company Information
  27. 8.5.2 Sealed Air Corporation Business Overview
  28. 8.5.3 Sealed Air Corporation Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sealed Air Corporation Pharmaceutical Active and Intelligent Packaging Product Portfolio
  30. 8.5.5 Sealed Air Corporation Recent Developments
  31. 8.6 Landec
  32. 8.6.1 Landec Company Information
  33. 8.6.2 Landec Business Overview
  34. 8.6.3 Landec Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Landec Pharmaceutical Active and Intelligent Packaging Product Portfolio
  36. 8.6.5 Landec Recent Developments
  37. 8.7 Honeywell International
  38. 8.7.1 Honeywell International Company Information
  39. 8.7.2 Honeywell International Business Overview
  40. 8.7.3 Honeywell International Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Honeywell International Pharmaceutical Active and Intelligent Packaging Product Portfolio
  42. 8.7.5 Honeywell International Recent Developments
  43. 8.8 Graphic Packaging
  44. 8.8.1 Graphic Packaging Company Information
  45. 8.8.2 Graphic Packaging Business Overview
  46. 8.8.3 Graphic Packaging Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Graphic Packaging Pharmaceutical Active and Intelligent Packaging Product Portfolio
  48. 8.8.5 Graphic Packaging Recent Developments
  49. 8.9 Dessicare
  50. 8.9.1 Dessicare Company Information
  51. 8.9.2 Dessicare Business Overview
  52. 8.9.3 Dessicare Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dessicare Pharmaceutical Active and Intelligent Packaging Product Portfolio
  54. 8.9.5 Dessicare Recent Developments
  55. 8.10 Crown Holdings
  56. 8.10.1 Crown Holdings Company Information
  57. 8.10.2 Crown Holdings Business Overview
  58. 8.10.3 Crown Holdings Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Crown Holdings Pharmaceutical Active and Intelligent Packaging Product Portfolio
  60. 8.10.5 Crown Holdings Recent Developments
  61. 8.11 Coveris Holdings
  62. 8.11.1 Coveris Holdings Company Information
  63. 8.11.2 Coveris Holdings Business Overview
  64. 8.11.3 Coveris Holdings Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Coveris Holdings Pharmaceutical Active and Intelligent Packaging Product Portfolio
  66. 8.11.5 Coveris Holdings Recent Developments
  67. 8.12 CCL Industrie
  68. 8.12.1 CCL Industrie Company Information
  69. 8.12.2 CCL Industrie Business Overview
  70. 8.12.3 CCL Industrie Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CCL Industrie Pharmaceutical Active and Intelligent Packaging Product Portfolio
  72. 8.12.5 CCL Industrie Recent Developments
  73. 8.13 Bemis Company
  74. 8.13.1 Bemis Company Company Information
  75. 8.13.2 Bemis Company Business Overview
  76. 8.13.3 Bemis Company Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bemis Company Pharmaceutical Active and Intelligent Packaging Product Portfolio
  78. 8.13.5 Bemis Company Recent Developments
  79. 8.14 Ball Corporation
  80. 8.14.1 Ball Corporation Company Information
  81. 8.14.2 Ball Corporation Business Overview
  82. 8.14.3 Ball Corporation Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ball Corporation Pharmaceutical Active and Intelligent Packaging Product Portfolio
  84. 8.14.5 Ball Corporation Recent Developments
  85. 8.15 Amcor
  86. 8.15.1 Amcor Company Information
  87. 8.15.2 Amcor Business Overview
  88. 8.15.3 Amcor Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Amcor Pharmaceutical Active and Intelligent Packaging Product Portfolio
  90. 8.15.5 Amcor Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst